According to a research report from China Merchants Securities, during the period surrounding the release of interim financial reports by listed companies, stocks experiencing upward revisions in earnings projections were mainly clustered within the pharmaceuticals sector (encompassing chemical preparations, medical R&D outsourcing, other biological products, and bulk pharmaceutical chemicals), the TMT sector (including digital chip design, Tier III IT services, vertical application software, communication network equipment and devices, Tier III gaming, printed circuit boards, and analog chip design), mid-to-high-end manufacturing (covering chassis and engine systems, other specialized equipment, energy and heavy equipment, Tier III aviation equipment, and lithium batteries), as well as in the securities, copper, pesticides, other chemical products, thermal power, and additional industries.